Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Neoplasms 28 Breast Neoplasms 17 Colorectal Neoplasms 14 Prostatic Neoplasms 13 Hematologic Neoplasms 7 Ovarian Neoplasms 6 Lung Neoplasms 6 Leukemia 5 Uterine Cervical Neoplasms 4 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Lymphoma 4 Endometrial Neoplasms 4 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pain 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Genetic Predisposition to Disease 3 Disease 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Mouth Neoplasms 2 Motor Activity 2 Melanoma 2 Low Anterior Resection Syndrome 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2

Interventions

Anastrozole 2 Weights and Measures 1 Leuprolide 1 Interviews as Topic 1 Goserelin 1 Clodronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Patient Compliance × Interviews as Topic × Clear all

NCT02896790 2017-07-26

MODAP

University Hospital, Bordeaux

Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡